A vaccine combining centralized ancestral genes from four major influenza strains appears to provide broad protection against the dangerous ailment, according to new research by a team from the Nebraska Center for Virology.
Mice protected by the unconventional vaccine survived exposure to lethal doses of seven of nine widely divergent influenza viruses. Those that received higher doses of the vaccine didn’t even get sick.
In contrast, mice that received traditional flu shots or nasal sprays all sickened and died when exposed to the same viruses. The deadly pathogens were able to evade the immune responses triggered by the traditional vaccines.
While it is too soon to say the approach could be successfully used in humans, it appears to be a promising avenue toward a universal flu shot, according to lead researcher Eric Weaver, an assistant professor in the School of Biological Sciences at the University of Nebraska-Lincoln.
Weaver said the study is the first to report on whether a universal flu shot could be created by using a combination of multiple genes shared at the ancestral level by flu strains circulating today.
“The ultimate goal is to be able to vaccinate once and provide lifelong protection,” Weaver said.
The Centers for Disease Control and Prevention estimates that 40 million Americans contracted influenza during the 2015-16 flu season and 970,000 people were hospitalized for the ailment. The agency estimated that vaccinations prevented about 1.9 million illnesses and 67,000 hospitalizations.
“To put this in other terms, our current influenza vaccine programs and technologies reduce influenza infections and hospitalizations by 4.75 percent and 6.9 percent, respectively,” Weaver said. “There is no doubt that there is a need for more effective vaccine technologies.”
Yet because the influenza virus mutates rapidly and because people, animals and birds often carry the virus without displaying symptoms, it’s been difficult to develop a vaccine with long-term effectiveness. The conventional influenza vaccine platform uses weakened or dead versions of the influenza virus to stimulate immunity against hemagglutinin (HA), a spike-shaped protein that extends from the surface of the virus and attacks cells.
According to a 2013 Clinical Microbiology Reviews article, the challenges of the conventional approach include predicting which flu strain will circulate in coming years; manufacturing and delivering safe, timely and adequate supplies; and poor responsiveness among the elderly, who often are the most vulnerable to influenza infection.
Conventional vaccines have been shown to be less than 60 percent effective when they’re successfully matched to the currently circulating strain. They’re far less effective when mismatched.
“An ideal influenza vaccine would be inexpensive, provide long-lasting immunity, require few immunizations and would work against all variants of the virus,” Weaver said.
Some experts say it could take until 2020 or 2025 before a universal flu vaccine is available.
Pursuit of a universal influenza vaccine has been difficult. Scientists are trying various approaches to better match vaccines to multiple viral strains. Other strategies include developing vaccines aimed at the virus’s protein coat, other proteins that have been found to be identical in multiple flu strains, or the stalk of the hemagglutinin protein rather than its head.
These approaches have shown promising results. However, Weaver said his study is the first to report the use of multiple centralized HA genes, identified using protein sequence analysis programs, to provide the greatest level of cross-protective immunity possible.
In the article published Nov. 2 in Scientific Reports, Weaver and his colleagues Amy Lingel and Brianna L. Bullard detail an approach they say is “scalable and translatable to humans and may provide the foundation for complete and long-lasting anti-influenza immunity.”
The idea arose from past research led by Dr. Bette Korber at Los Alamos National Laboratories to discover the ancestral genes for the Human Immunodeficiency Virus and to pinpoint when that virus jumped from monkeys to man. Weaver was involved with that effort while a post-doctoral researcher at Duke University School of Medicine. He and his colleagues decided to try a similar concept with the influenza virus, synthesizing genes that are central to influenza’s phylogenetic tree.
Instead of using weakened or deadened flu virus, his experiments at the Nebraska Center for Virology have used replication-defective Adenoviruses – which cause the common cold – that have been altered to carry what he calls consensus genes for H1, H2, H3 and H5 influenza strains. The vaccine is no longer capable of causing cold symptoms, but is still able to safely deliver the influenza vaccine genes.
“Our idea is that these centralized antigens can set up a foundation of immunity against influenza,” he said. “Because they are centralized and represent all the strains equally, they could provide a basis for immunity against all evolved strains.”
Learn more: 4-in-1 flu shot may mean lifelong protection against the flu
The Latest on: Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Avian Influenza: Take steps to help protect your poultryon May 9, 2024 at 3:00 am
The Centers for Disease Control and Protection (CDC) reports that H5N1 avian influenza (bird flu) "is widespread in wild birds worldwide and is causing outbreaks in poultry and US dairy ...
- Bird flu has spread to cows in Colorado. Is avian influenza threat? We answer your questions.on May 8, 2024 at 9:06 am
The bird flu has arrived in Colorado, and while it doesn’t represent anywhere near the threat that COVID-19 did at the beginning of the pandemic, people should take some precautions with animals that ...
- NYS Dept. of Health Says Flu 'No Longer Prevalent in New York' for 2023-24 Influenza Seasonon May 8, 2024 at 8:52 am
Health Commissioner Dr. James McDonald has officially stated that the flu is no longer widespread in the State for the 2023-24 influenza season. As a result, the masking mandate for unvaccinated ...
- Masks off: Health care workers, without flu vaccine, no longer required to wear a maskon May 8, 2024 at 8:48 am
As of Wednesday, the New York State Department of Health no longer requires health care workers without the influenza vaccine to wear a mask.
- Experts provide facts about avian influenza for dairy producerson May 7, 2024 at 10:05 am
While a strain of highly pathogenic avian influenza virus has been detected in dairy cattle in nine states—not including New York state—the commercial milk supply continues to be safe, according to a ...
- Bird Flu: U.S. Could Produce and Ship 100 Million Vaccine Doses Within Monthson May 7, 2024 at 8:56 am
There is no sign that the H5N1 bird flu circulating in dairy cow herds is developing the ability to spread easily to people. But federal health officials are planning for the rollout of a bird flu ...
- Children born during COVID pandemic urged to get flu vaccineon May 6, 2024 at 1:04 pm
Parents of children born during the COVID-19 pandemic are being urged to get their children flu shots, with almost 5,000 cases in children aged zero to four so far this year.
- Could Avian Influenza Be The Next Covid-19?on May 6, 2024 at 11:08 am
H5N1 has been detected in over 9,000 wild birds, 90 million poultry and in dairy cattle. A recent human case in Texas has some asking if this could be the next pandemic.
- Diet and metabolic health may influence flu vaccine effectivenesson May 6, 2024 at 7:54 am
A study conducted in obese mice found that dietary interventions resulting in weight loss led to better metabolic biomarkers and improved flu vaccine effectiveness. The results highlight the potential ...
- New influenza vaccine strategies aim to enhance protection with T-cell responseson May 5, 2024 at 11:13 pm
A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.
via Google News and Bing News